Summary
David Hunter is an entrepreneurial medical device leader with 15 years in biomedical engineering and a decade of startup-focused leadership, currently directing applied research and strategy at Galvanize Therapeutics. He builds cross-functional teams that translate early-stage concepts through translational preclinical work to regulatory milestones (IDE and 510(k)), blending technical depth in cardiac EP and ablation modalities with practical commercialization experience. His background spans founding and scaling VC-backed ventures, consulting across diverse clinical areas, and publishing strategies that drive adoption of novel therapies. Trained at Johns Hopkins with a PhD and postdoctoral work in cardiac electrophysiology, he couples rigorous research instincts with hands-on engineering (deep learning, neuroscience, robotics interests). Colleagues rely on him to find competitive advantage through people, clear communication, and evidence-driven product fit. An often-overlooked strength is his ability to move projects from proof-of-concept experiments to funded clinical feasibility studies while keeping multidisciplinary stakeholders aligned.
8 years of coding experience
15 years of employment as a software developer
Post doctoral fellowship, Cardiology (EP), Post doctoral fellowship, Cardiology (EP) at The Johns Hopkins University School of Medicine
B.S., Electrical Engineering (Major), Business Administration (Minor), Mathematics (Minor), Summa Cum Laude (3.97), B.S., Electrical Engineering (Major), Business Administration (Minor), Mathematics (Minor), Summa Cum Laude (3.97) at University of Maine